Lithium carbonate in the treatment of tardive dyskinesia

Six patients with tardive dyskinesia were treated with lithium carbonate in an open clinical trial. Evaluations using a new tardive dyskinesia rating scale showed statistically significant improvement in dyskinetic movements while the patients received lithium. This improvement was consistently obse...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of psychiatry 1975-05, Vol.132 (5), p.560-562
Hauptverfasser:	Reda, F A, Escobar, J I, Scanlan, J M
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antidepressive Agents - adverse effects Bipolar Disorder - drug therapy Carbonates Female Humans Lithium - therapeutic use Long-Term Care Male Middle Aged Movement Disorders - chemically induced Movement Disorders - drug therapy Psychotropic Drugs - adverse effects Psychotropic Drugs - therapeutic use Schizophrenia - drug therapy Tranquilizing Agents - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Six patients with tardive dyskinesia were treated with lithium carbonate in an open clinical trial. Evaluations using a new tardive dyskinesia rating scale showed statistically significant improvement in dyskinetic movements while the patients received lithium. This improvement was consistently observed in all patients but was relatively small when compared to the amount of pathology present.
ISSN:	0002-953X 1535-7228
DOI:	10.1176/ajp.132.5.560